Politics
A promising new medicine against heart disease fails unexpectedly
NPR News·November 7, 2026·1 min read
An experimental drug designed to lower a common risk factor for heart attacks failed to save patients' lives in a trial, surprising doctors who had expected a benefit. The medicine made no difference in outcomes, casting doubt on the strategy of targeting that risk factor alone to reduce mortality from cardiovascular disease.
Read at NPR NewsDaily crypto arcade
Read the news, then play it.
Chainshorts turns crypto headlines into a daily game. Catch up in 60 words, then jump into daily lucky draws for a shot at the pot.